FZRQ — Immune Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Immune Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.76 | -23.6 | -17.2 | -32.7 | -17.9 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.121 | 13.1 | 3.09 | 23.8 | 8.04 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.71 | -3.73 | -0.079 | 1.13 | -0.571 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.87 | -13.9 | -13.8 | -12.3 | -11.6 |
| Capital Expenditures | 0 | -0.023 | -0.167 | -0.021 | -0.028 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1.13 | 0.14 | -0.01 | -0.029 | 0.059 |
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.13 | 0.117 | -0.177 | -0.05 | 0.031 |
| Financing Cash Flow Items | 0.5 | 9.67 | 10.4 | -0.505 | -0.947 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.95 | 20.5 | 11.9 | 8.09 | 18 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.046 | 6.72 | -2.13 | -4.27 | 6.5 |